BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1869367)

  • 1. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
    Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
    Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
    Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
    Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
    Mezö G; Szekerke M; Sármay G; Gergely J
    Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of [L-hydroxyproline]3-tuftsin analogue and its alpha- or beta-O-D-glucosylated derivatives.
    Biondi L; Filira F; Rocchi R; Tzehoval E; Fridkin M
    Int J Pept Protein Res; 1993 Jan; 41(1):43-51. PubMed ID: 8436445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of glycosylated tuftsins and tuftsin-containing IgG fragment undecapeptide.
    Biondi L; Filira F; Gobbo M; Scolaro B; Rocchi R
    Int J Pept Protein Res; 1991 Feb; 37(2):112-21. PubMed ID: 2019473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
    Buchta R; Fridkin M; Pontet M; Romeo D
    Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunomodulatory activity of tetra- and tripeptides of tuftsin-kentsin group.
    Wieczorek Z; Zimecki M; Słoń JJ; Siemion IZ
    Peptides; 1994; 15(2):215-21. PubMed ID: 8008626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.
    Martinez J; Winternitz F
    Ann N Y Acad Sci; 1983; 419():23-34. PubMed ID: 6585171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between tuftsin and HBV S-protein sequences.
    Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
    Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K; Obeyesekere NU; McMurray JS
    Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.
    Gershonov E; Granoth R; Tzehoval E; Gaoni Y; Fridkin M
    J Med Chem; 1996 Nov; 39(24):4833-43. PubMed ID: 8941397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evidence on the possible interleukin-1 alpha tuftsin competition.
    Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of [Leu1]Tuftsin and tuftsin, a natural phagocytosis-stimulating peptide.
    Nishioka K; Hurr KJ; Dessens SE; Rodriguez T
    Int J Biochem; 1991; 23(5-6):627-30. PubMed ID: 2065822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification.
    Verdini AS; Silvestri S; Becherucci C; Longobardi MG; Parente L; Peppoloni S; Perretti M; Pileri P; Pinori M; Viscomi GC
    J Med Chem; 1991 Dec; 34(12):3372-9. PubMed ID: 1766001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory potential of hydrophobic analogs of Rigin and their role in providing protection against Plasmodium berghei infection in mice.
    Dutta RC; Puri A; Anand N
    Int Immunopharmacol; 2001 May; 1(5):843-55. PubMed ID: 11379040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.